boosting their US manufacturing presence to avoid a potential 25% tariff on imported pharma products. Although World Trade Organization rules exempt most pharmaceuticals and their starting ...

In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR ...

Pfizer’s local manufacturing setup is already well positioned ... Bourla made his comment against a backdrop of uncertainty as pharma execs and industry watchers weigh the effects of potential ...

along with the time and cost investments required for technology transfer to manufacturing facilities, presents additional hurdles. In Tokyo, Astellas Pharma shares were trading at 1,481.00 yen ...

These are witnessing a growth at 13-14 per cent CAGR, surpassing conventional drug growth. Notably, the pharma sector in India has seen an increase in the number of US Food and Drug Administration ...